Corporate Industry Symposia

The basis of bone-building: Exploring the mechanisms by which bone-forming therapies impact bone strength

Sunday May 8th 2022 – Auditorium 103


14:45 – 14:50 EEST Welcome and introduction Ralph Müller (Switzerland)
14:50 – 15:05 EEST The anatomical significance of bone modeling and remodeling Ralph Müller (Switzerland)
15:05 – 15:20 EEST The impact of bone-forming therapies on cortical and trabecular bone structure Richard Abel (United Kingdom)
15:20 – 15:35 EEST Translating therapeutic effects into clinical outcomes Roland Chapurlat (France)
15:35 – 16:10 EEST Q&A/panel discussion All, led by Ralph Müller (Switzerland)
16:10 – 16:15 EEST Conclusion and closing remarks Ralph Müller (Switzerland)

This symposium is sponsored and organised by UCB and co-supported by Amgen.

Corporate Mini Symposia

Osteoporosis: the link between experimental findings and clinical observations

Saturday May 7th 2022 – Auditorium 103


13:30 – 13:40 EEST Welcome and introduction Heikki Kröger (Finland)
13:40 – 14:15  EEST New insights into denosumab mechanisms of action in relation to its long-term and off-treatment effects on bone Serge Ferrari (Switzerland)
14:15 – 14:30 EEST Q&A session and meeting close Serge Ferrari (Switzerland)

Heikki Kröger (Finland)

Núria Guañabens (Spain)


Exploring how people living with Rare Bone Diseases can contribute to the drug development process: Design for them or with them?

Supported by an independent educational grant from Ipsen

Sunday May 8th 2022 – Meeting room 207


19:00 – 19:10 EEST Collaborative research with people living with Rare Bone Diseases and advocates – why, when, and how Inês Alves (Portugal)
19:10 – 19:25 EEST Exploring how people living with Rare Bone Diseases can inform Early Research Oliver Semler (Germany)
19:25 – 19:40 EEST Exploring how people living with Rare Bone Diseases can inform Clinical Research Clemens Stockklausner (Germany)
19:40 – 20:00 EEST Panel discussion and Q&A All, led by Inês Alves (Portugal)